Immunotherapy has shown promise in many solid tumors including melanoma and non-small cell lung cancer with an evolving role in breast cancer. Immunotherapy encompasses a wide range of therapies including immune checkpoint inhibition, monoclonal antibodies, bispecific antibodies, vaccinations, antibody-drug ...
3Dept of Medicine, Universitat Ulm, Ulm, Germany. 4Univeristat Ulm, Ulm, Germany. 5British Columbia Cancer Agency, Vancouver, Canada. 6General Internal Medicine (111-0), Minneapolis VA Medical Center, Minneapolis, Minnesota, USACoppinPorzsoltAutenriethKumpfColdman...
Immunotherapy for cancer has undergone a rapid expansion in classes, agents, and indications. By utilizing aspects of the body’s innate immune system, immunotherapy has improved life expectancy and quality of life for patients with several types of cancer. Adoptive cellular therapies, including chimer...
There have been major advances in the immunotherapy of cancer in recent years, including the development of T cell engagers — antibodies engineered to redirect T cells to recognize and kill cancer cells — for the treatment of haematological malignancies. However, the field still faces several chal...
& Ung, Y. Immune checkpoint inhibitors for patients with advanced non–small-cell lung cancer: a systematic review. Clin. Lung Cancer 18, 444–459 (2017). CAS PubMed Google Scholar Friedman, C., Proverbs-Singh, T. & Powtow, M. Treatment of the immune-related adverse effects of immune...
Immunotherapy for nasopharyngeal cancer--a review. Chin Clin Oncol 2016;5:22... A Jain,WK Chia,CT Han - 《Chin Clin Oncol》 被引量: 15发表: 2016年 Updates in Cancer Immunotherapy: Review Article Background: An adaptable group of cells called the immune system in human's works together ...
Esophageal cancer (EC) is one of the most common types of cancer worldwide and was ranked as the sixth leading cause of cancer-related deaths in 2020. When EC is localized or locally advanced, referred to as resectable EC, surgery is usually the preferre
Publications are an excellent indicator for identifying the trend of cancer immunotherapy. Hence, we decided to evaluate the current status of tumor-specific cancer immunotherapy and its progress based on the number of publications in different therapeutic modalities in Iran. In this review, we first...
These are exciting times for cancer immunotherapy. After many years of disappointing results, the tide has finally changed and immunotherapy has become a clinically validated treatment for many cancers. Immunotherapeutic strategies include cancer vaccine
This review provides a comprehensive overview of the distinct roles exhibited by TNFR2 agonists and antagonists against tumors. The signal pathways, functions for cancer immunotherapy of TNFR2, as well as binding modes of the antibody-TNFR2 complex have been discussed in detailed. Moreover, the ...